These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17616688)

  • 21. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
    Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
    Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of non-small cell lung cancer proliferation and tumorigenicity by DENND2D.
    Ling B; Zheng H; Fu G; Yuan J; Shi T; Chen S; Liu Y; Liu Y; Cao Y; Zheng S; Guo S; Han N; Gao Y; Cheng S; Zhang K
    Lung Cancer; 2013 Feb; 79(2):104-10. PubMed ID: 23182661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ex vivo assessment of chemotherapy-induced apoptosis and associated molecular changes in patient tumor samples.
    Pirnia F; Frese S; Gloor B; Hotz MA; Luethi A; Gugger M; Betticher DC; Borner MM
    Anticancer Res; 2006; 26(3A):1765-72. PubMed ID: 16827105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cationic liposome-mediated nitric oxide synthase gene therapy enhances the antitumor effects of cisplatin in lung cancer.
    Ye S; Yang W; Wang Y; Ou W; Ma Q; Yu C; Ren J; Zhong G; Shi H; Yuan Z; Su X; Zhu W
    Int J Mol Med; 2013 Jan; 31(1):33-42. PubMed ID: 23128378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of alpha CP-4 inhibits cell cycle progression and suppresses tumorigenicity of lung cancer cells.
    Castaño Z; Vergara-Irigaray N; Pajares MJ; Montuenga LM; Pio R
    Int J Cancer; 2008 Apr; 122(7):1512-20. PubMed ID: 17973258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
    Katiyar SK; Meeran SM; Katiyar N; Akhtar S
    Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autophagy Inhibition Overcomes the Antagonistic Effect Between Gefitinib and Cisplatin in Epidermal Growth Factor Receptor Mutant Non--Small-Cell Lung Cancer Cells.
    Liu JT; Li WC; Gao S; Wang F; Li XQ; Yu HQ; Fan LL; Wei W; Wang H; Sun GP
    Clin Lung Cancer; 2015 Sep; 16(5):e55-66. PubMed ID: 25979647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced tumor suppression by an ING4/IL-24 bicistronic adenovirus-mediated gene cotransfer in human non-small cell lung cancer cells.
    Zhu Y; Lv H; Xie Y; Sheng W; Xiang J; Yang J
    Cancer Gene Ther; 2011 Sep; 18(9):627-36. PubMed ID: 21660060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-specific, hypoxia-regulated, WW domain-containing oxidoreductase-expressing adenovirus inhibits human non-small cell lung cancer growth in vivo.
    Zhang P; Ying L; Xu R; Ge S; Mei W; Li F; Dai B; Lu J; Qian G
    Hum Gene Ther; 2010 Jan; 21(1):27-39. PubMed ID: 19737107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Putative tumor suppressor Lats2 induces apoptosis through downregulation of Bcl-2 and Bcl-x(L).
    Ke H; Pei J; Ni Z; Xia H; Qi H; Woods T; Kelekar A; Tao W
    Exp Cell Res; 2004 Aug; 298(2):329-38. PubMed ID: 15265683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death.
    Wang G; Li X; Huang F; Zhao J; Ding H; Cunningham C; Coad JE; Flynn DC; Reed E; Li QQ
    Cell Mol Life Sci; 2005 Apr; 62(7-8):881-93. PubMed ID: 15868411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphological changes and nuclear translocation of DLC1 tumor suppressor protein precede apoptosis in human non-small cell lung carcinoma cells.
    Yuan BZ; Jefferson AM; Millecchia L; Popescu NC; Reynolds SH
    Exp Cell Res; 2007 Nov; 313(18):3868-80. PubMed ID: 17888903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spectral characterization of the recombinant mouse tumor suppressor 101F6 protein.
    Bérczi A; Desmet F; Van Doorslaer S; Asard H
    Eur Biophys J; 2010 Jul; 39(8):1129-42. PubMed ID: 19943161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myristoylation of the fus1 protein is required for tumor suppression in human lung cancer cells.
    Uno F; Sasaki J; Nishizaki M; Carboni G; Xu K; Atkinson EN; Kondo M; Minna JD; Roth JA; Ji L
    Cancer Res; 2004 May; 64(9):2969-76. PubMed ID: 15126327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversine Induced Multinucleated Cells, Cell Apoptosis and Autophagy in Human Non-Small Cell Lung Cancer Cells.
    Lu YC; Lee YR; Liao JD; Lin CY; Chen YY; Chen PT; Tseng YS
    PLoS One; 2016; 11(7):e0158587. PubMed ID: 27385117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Novel Autophagy Inhibitor Alpha-Hederin Promoted Paclitaxel Cytotoxicity by Increasing Reactive Oxygen Species Accumulation in Non-Small Cell Lung Cancer Cells.
    Zhan Y; Wang K; Li Q; Zou Y; Chen B; Gong Q; Ho HI; Yin T; Zhang F; Lu Y; Wu W; Zhang Y; Tan Y; Du B; Liu X; Xiao J
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30340379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor suppressor FUS1 signaling pathway.
    Ji L; Roth JA
    J Thorac Oncol; 2008 Apr; 3(4):327-30. PubMed ID: 18379348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transient Systemic Autophagy Inhibition Is Selectively and Irreversibly Deleterious to Lung Cancer.
    Khayati K; Bhatt V; Lan T; Alogaili F; Wang W; Lopez E; Hu ZS; Gokhale S; Cassidy L; Narita M; Xie P; White E; Guo JY
    Cancer Res; 2022 Dec; 82(23):4429-4443. PubMed ID: 36156071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoparticle based systemic gene therapy for lung cancer: molecular mechanisms and strategies to suppress nanoparticle-mediated inflammatory response.
    Gopalan B; Ito I; Branch CD; Stephens C; Roth JA; Ramesh R
    Technol Cancer Res Treat; 2004 Dec; 3(6):647-57. PubMed ID: 15560723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene Therapy for Lung Cancer.
    Lara-Guerra H; Roth JA
    Crit Rev Oncog; 2016; 21(1-2):115-24. PubMed ID: 27481008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.